Search

Filters

Clear Filters
5:25 PM - 5:35 PM PT

144 - Early Outcomes of a Phase III Randomized Controlled Trial Comparing Ultra-Hypo Fractionated 5 Fraction Treatment vs. Hypofractionated 15 Fraction Treatment for Patients Receiving Regional Nodal Irradiation
Speaker: Vargas, Carlos, MD - Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ
5:35 PM - 5:45 PM PT

145 - Ultra-Hypofractionated Partial Breast Re-Irradiation for Ipsilateral Breast Cancer Recurrence
Speaker: Nassif, Tracy, MD - Corewell Health William Beaumont University Hospital, Royal Oak, MI
4:45 PM - 4:55 PM PT

146 - Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy
Speaker: Zhao, Dekuang, DO, PhD - Moffitt Cancer Center, Tampa, FL
4:55 PM - 5:05 PM PT

147 - Bladder-Specific 15-Gene Transcriptomic Signature Predicts (Chemo)radiation Therapy Response in Muscle-Invasive Bladder Cancer
Speaker: Li, Xiaohui, MD - Department of Medical Oncology, Peking University First Hospital, Beijing
5:05 PM - 5:15 PM PT

148 - Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Four-year outcomes of a phase II clinical trial
Speaker: Juarez Casillas, Jesus, MD, MS - UCLA, Los Angeles, CA
5:15 PM - 5:25 PM PT

149 - Quality of Life after Adjuvant or Salvage Radiotherapy Following Radical Prostatectomy: A Secondary Analysis of the TROG 08.03 RAVES Randomized Controlled Trial
Speaker: Smith, Justin, MBBS - Princess Alexandra Hospital, Woolloongabba, QLD
5:25 PM - 5:35 PM PT

150 - Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence
Speaker: Arcangeli, Stefano, MD - University of Milan Bicocca, Milan, Milan
5:35 PM - 5:45 PM PT

151 - Bladder Only vs. Whole Pelvis Radiotherapy in Trimodality Treatment for Lymph Node Negative Urothelial Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Speaker: Granda, Alyssa Anne, MD - Jose R. Reyes Memorial Medical Center, Manila
4:45 PM - 4:55 PM PT

152 - Integration of Circulating Tumor HPV-DNA with PET/CT for Improved Surveillance of HPV-Associated Oropharyngeal Cancer: A Secondary Analysis of a Prospective Trial
Speaker: Kawakibi, Abed Rahman, MD - Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL
4:55 PM - 5:05 PM PT

153 - HPV ctDNA Kinetics during Radiation and in Surveillance in a Phase II De-Escalation Trial for Early-Stage p16+ Oropharynx Cancer
Speaker: Higgins, Luke, MD - University of Michigan, Ann Arbor, MI
5:05 PM - 5:15 PM PT

154 - The Influence of Chemo-Radiotherapy Dose and Radiotherapy Volumes on Peripheral Immunity in HPV+ Oropharyngeal Cancer
Speaker: Riaz, Nadeem, MD, MS - memorial sloan kettering, new york, New York
5:15 PM - 5:25 PM PT

155 - A Phase IV Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) as a Standard of Care in Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma
Speaker: Hidalgo, Cecelia - Mayo Clinic, Scottsdale, AZ